Effects of Social Support on Medication Adherence Among Patients with Schizophrenia: Serial Multiple Mediation Model

References

• Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86–97.
   PubMed Web of Science ®Google Scholar
• Lashgari N-A, Roudsari NM, Shamsnia HS, Shayan M, Momtaz S, Abdolghaffari AH. TLR/mTOR inflammatory signaling pathway: novel insight for the treatment of schizophrenia. Can. J. Physiol. Pharmacol. 2023.
   PubMedGoogle Scholar
• Edition F. Diagnostic and statistical manual of mental disorders. Am Psychiatr Assoc. 2013;21(21):591–643.
   Google Scholar
• James SLG, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.
   PubMed Web of Science ®Google Scholar
• Yao L, Liu H, Tian X. Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: a cross-sectional study. Psychiatry Res. 2022;317:114841.
   PubMed Web of Science ®Google Scholar
• Tham XC, Xie H, Chng CML, Seah XY, Lopez V, Klainin-Yobas P. Factors affecting medication adherence among adults with schizophrenia: a literature review. Arch Psychiatric Nursing. 2016;30(6):797–809.
   PubMed Web of Science ®Google Scholar
• Townsend M, Pareja K, Buchanan-Hughes A, et al. Antipsychotic-related stigma and the impact on treatment choices: a systematic review and framework synthesis. Patient Preference Adherence. 2022;373–401.
   PubMed Web of Science ®Google Scholar
• Sendt K-V, Tracy DK, Bhattacharyya S. A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Res. 2015;225(1–2):567.
   Web of Science ®Google Scholar
• Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159(10):1653–1664.
   PubMed Web of Science ®Google Scholar
• Clifford L, Crabb S, Turnbull D, Hahn L, Galletly C. A qualitative study of medication adherence amongst people with schizophrenia. Arch Psychiatric Nursing. 2020;34(4):194–199.
   PubMed Web of Science ®Google Scholar
• Hsieh WL, Lee SK, Chien WT, Liu WI, Lai CY, Liu CY. Mediating effect of the motivation for medication use on disease management and medication adherence among community-dwelling patients with schizophrenia. Patient Preference Adherence. 2019;1877–1887.
   PubMed Web of Science ®Google Scholar
• Cahaya N, Kristina SA, Widayanti AW, Green J. Interventions to improve medication adherence in people with schizophrenia: a systematic review. Patient Preference Adherence. 2022;2431–2449.
   PubMed Web of Science ®Google Scholar
• De Las Cuevas C. Psychiatric Patients’ perceived health control and reactance: implications for medication adherence. Patient Preference Adherence. 2023;1591–1601.
   PubMed Web of Science ®Google Scholar
• Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin. 1997;23(4):637–651.
   PubMed Web of Science ®Google Scholar
• Loots E, Goossens E, Vanwesemael T, Morrens M, Van Rompaey B, Dilles T. Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(19):10213.
   PubMed Web of Science ®Google Scholar
• Robinson DG, Woerner MG, Alvir JMJ, Bilder RM, Hinrichsen GA, Lieberman JA. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res. 2002;57(2–3).
   PubMed Web of Science ®Google Scholar
• Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW. Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry. 2004;65(3):354–360.
   PubMed Web of Science ®Google Scholar
• Lincoln TM, Lüllmann E, Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophrenia Bulletin. 2007;33(6):1324–1342.
   PubMed Web of Science ®Google Scholar
• Grenard JL, Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26:1175–1182.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207.
   PubMed Web of Science ®Google Scholar
• Dumont M, Provost MA. Resilience in adolescents: protective role of social support, coping strategies, self-esteem, and social activities on experience of stress and depression. Journal of Youth and Adolescence. 1999;28(3):343–363.
   Web of Science ®Google Scholar
• Chen H, Phillips MR, Cheng H, et al. Mental Health Law of the People’s Republic of China (English translation with annotations): translated and annotated version of China’s new Mental Health Law. Shanghai Arch Psychiatry. 2012;24(6):305.
   PubMedGoogle Scholar
• Fan C-H, Hsu S-C, Hsiao F-H, et al. The association of social support and symptomatic remission among community-dwelling schizophrenia patients: a cross-sectional study. Int J Environ Res Public Health. 2021;18(8):3977.
   PubMed Web of Science ®Google Scholar
• Subotnik KL, Nuechterlein KH, Ventura J, et al. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. Am J Psychiatry. 2011;168(3):286–292.
   PubMed Web of Science ®Google Scholar
• Manning WG, Wells KB. The Effects of Psychological Distress and Psychological Well-Being on Use of Medical Services. Med Care. 1992;30(6):541–553.
   PubMed Web of Science ®Google Scholar
• Battaglia S, Di Fazio C, Mazzà M, Tamietto M, Avenanti A. Targeting Human Glucocorticoid Receptors in Fear Learning: a Multiscale Integrated Approach to Study Functional Connectivity. Int J Mol Sci. 2024;25(2):864.
   PubMed Web of Science ®Google Scholar
• Jászberényi M, Thurzó B, Bagosi Z, Vécsei L, Tanaka M. The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress. Biomedicines. 2024;12(2):448.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Szabo A, Vecsei L, Gimenez-Llort L. Emerging Translational Research in Neurological and Psychiatric Diseases: from In Vitro to In Vivo Models. Int J Mol Sci. 2023;24(21):2724.
   PubMed Web of Science ®Google Scholar
• Battaglia S, Avenanti A, Vecsei L, Tanaka M. Neural Correlates and Molecular Mechanisms of Memory and Learning. Int J Mol Sci. 2024;25(5):2724.
   PubMed Web of Science ®Google Scholar
• Higashi K, Medic G, Littlewood KJ, Diez T, Granström O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Adv Psychopharmacol. 2013;3(4):200–218.
   PubMedGoogle Scholar
• Piette JD, Richardson C, Valenstein M. Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care. 2004;10(2):152–162.
   PubMed Web of Science ®Google Scholar
• Kilbourne AM, Reynolds CF, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatric Psychiatry. 2005;13(3):202–210.
   PubMed Web of Science ®Google Scholar
• X-H L, Zhang T-M, Yau YY, et al. Peer-to-peer contact, social support and self-stigma among people with severe mental illness in Hong Kong. Int J Social Psychiatry. 2021;67(6):622–631.
   PubMed Web of Science ®Google Scholar
• Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc sci med. 2010;71(12):2150–2161.
   PubMed Web of Science ®Google Scholar
• Ran M-S, Zhang T-M, Wong IY-L, et al. Internalized stigma in people with severe mental illness in rural China. Int J Social Psychiatry. 2018;64(1):9–16.
   PubMed Web of Science ®Google Scholar
• Zhang T-M, Wong IY-L, Y-H Y, et al. An integrative model of internalized stigma and recovery-related outcomes among people diagnosed with schizophrenia in rural China. Social Psychiatry Psychiatric Epidemiol. 2019;54:911–918.
   PubMed Web of Science ®Google Scholar
• Uchino BN, Uno D, Holt-Lunstad J. Social support, physiological processes, and health. Curr Directions Psychological Sci. 1999;8(5):145–148.
   Web of Science ®Google Scholar
• Jiang N, Shi H, Zhao J, et al. Effects of social support on oral health behavior: serial multiple‐mediator model. Oral Dis. 2022.
   Web of Science ®Google Scholar
• Birtel MD, Wood L, Kempa NJ. Stigma and social support in substance abuse: implications for mental health and well-being. Psychiatry Res. 2017;252:1–8.
   PubMed Web of Science ®Google Scholar
• Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310.
   PubMed Web of Science ®Google Scholar
• Wedajo S, Degu G, Deribew A, Ambaw F. Social support, perceived stigma, and depression among PLHIV on second-line antiretroviral therapy using structural equation modeling in a multicenter study in Northeast Ethiopia. Int J Mental Health Systems. 2022;16(1).
   PubMed Web of Science ®Google Scholar
• Qiu L, Tong Y, Lu Z, Gong Y, Yin X. Depressive Symptoms Mediate the Associations of Stigma with Medication Adherence and Quality of Life in Tuberculosis Patients in China. Am. J. Trop. Med. Hyg. 2019;100(1):31–36.
   PubMed Web of Science ®Google Scholar
• Jiang M, Yang J, Song Y, et al. Social support, stigma, and the mediating roles of depression on self-reported medication adherence of HAART recipients in China. AIDS Care. 2019;31(8):942–950.
   PubMed Web of Science ®Google Scholar
• Fritz MS, MacKinnon DP. Required sample size to detect the mediated effect. Psychol Sci. 2007;18(3):233–239.
   PubMed Web of Science ®Google Scholar
• Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Personality Assessment. 1988;52(1):30–41.
   Web of Science ®Google Scholar
• Molina Y, Choi SW, Cella D, Rao D. The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions. Int j Behav Med. 2013;20:450–460.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta psychiatrica scandinavica. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Okubo R, Koga M, Katsumata N, et al. Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: a proof-of-concept study. J Affective Disorders. 2019;245:377–385.
   PubMed Web of Science ®Google Scholar
• Allan R, Martin CR. Can the Hospital Anxiety and Depression Scale be used in patients with schizophrenia? J Evaluation Clin Practice. 2009;15(1):134–141.
   PubMed Web of Science ®Google Scholar
• Thompson K, Kulkarni J, Sergejew A. Reliability and validity of a new Medication Adherence Rating Scale (Mars) for the psychoses. Schizophr Res. 2000;42(3):241–247.
   PubMed Web of Science ®Google Scholar
• Owie GO, Olotu SO, James BO. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria. Trends Psychiatry Psychother. 2018;40:85–92.
   PubMedGoogle Scholar
• Sowunmi O, Onifade P. Psychometric evaluation of medication adherence rating scale (Mars) among Nigerian patients with schizophrenia. Niger J Clin Pract. 2019;22(9):1281–1285.
   PubMed Web of Science ®Google Scholar
• Wang D, Ross B, Xi C, et al. Medication adherence and its correlates among patients affected by schizophrenia with an episodic course: a large-scale multi-center cross-sectional study in China. Asian J Psychiatry. 2020;53:102198.
   PubMed Web of Science ®Google Scholar
• Yu Y, Li T-X. A cross-sectional study on spouse and parent differences in caregiving experiences of people living with schizophrenia in rural China. BMC Psychiatry. 2020;20(1):1–13.
   PubMed Web of Science ®Google Scholar
• Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–a review of the past decade. Eur Psychiatry. 2012;27(1):9–18.
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl J, Record EJ, Palmer-Bacon J. A review of behavioral tailoring strategies for improving medication adherence in serious mental illness. Dialogues clin neuroscience. 2016;18(2):191–201.
   PubMed Web of Science ®Google Scholar
• Liu-Seifert H, Osuntokun OO, Feldman PD. Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia. Comprehensive Psychiatry. 2012;53(1):107–115.
   PubMed Web of Science ®Google Scholar
• Ambaw F, Mayston R, Hanlon C, Alem A. Depression among patients with tuberculosis: determinants, course and impact on pathways to care and treatment outcomes in a primary care setting in southern Ethiopia—a study protocol. BMJ open. 2015;5(7):e007653.
   PubMed Web of Science ®Google Scholar
• Wang P, Xiong J, Zheng J, Chai C, Wang Y. Perceived social support and depression among people living with HIV in China: roles of stigma and adherence self-efficacy. BMC Psychiatry. 2023;23(1):544.
   PubMed Web of Science ®Google Scholar
• Gariepy G, Honkaniemi H, Quesnel-Vallee A. Social support and protection from depression: systematic review of current findings in Western countries. Br J Psychiatry. 2016;209(4):284–293.
   PubMed Web of Science ®Google Scholar
• Cha E, Erlen JA, Kim KH, Sereika SM, Caruthers D. Mediating roles of medication–taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: a questionnaire survey. Int j Nursing Studies. 2008;45(8):1175–1184.
   PubMed Web of Science ®Google Scholar
• Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bouzoño M. Quality of life in schizophrenic patients. Dialogues clin neuroscience. 2022.
   Google Scholar